A company called Marinus made a medicine called IV Ganaxolone that they hoped would help people with a brain problem. They did a big test with many patients to see if it works, but the test did not show clear results yet. Some experts are worried about whether this medicine can make enough money for the company. So, some of them think Marinus should focus on another type of medicine called oral Ganaxolone that might be better. The final answers will come later when they check all the data from the test. Read from source...

1. The article title is misleading and sensationalized. It implies that Marinus' IV ganaxolone failed to meet its primary endpoint, but it only mentions an interim analysis that did not reach the stopping criteria. This does not necessarily mean that the drug is ineffective or harmful. A final analysis will be conducted later, and it might show different results. The title should reflect this uncertainty and potential for change.